7/30/2026 3:24:22 PM Ambient Scribing in the NHS: A Compliance Framework Suppliers Cannot Ignore By Moona Malik Pieter Erasmus Ambient voice technologies ("AVTs") are AI-enabled tools that automatically transcribe and document clinical conversations, and we are...
7/27/2026 8:51:31 AM Is Your Healthcare AI Tool a Medical Device? What the CJEU's Latest MDR Decision Means for Digital Health Companies By Christian Lindenthal Clarissa Junge-Gierse Annelie Säurig The Court of Justice of the European Union (CJEU, 2 July 2026, Case C-427/24, Diagramm Halbach) has recently issued an important judgment...
1/15/2026 1:56:33 PM Understanding the impact of the European Accessibility Act on Medical Devices By Kelly Mackey Deirdre Kilroy Understanding the impact of the European Accessibility Act on Medical Devices The European Accessibility Act (Directive (EU) 2019/882)...
10/27/2025 11:54:53 AM Navigating the interplay of MDR and AIA: New MDCG Guidance on Medical Device AI Under the EU AI Act: EU and UK perspectives By Pieter Erasmus Maud van Haaren Hester Borgers The EU regulatory landscape for medical devices making use of artificial intelligence (MDAI) has become significantly more complex with...
9/4/2025 4:43:11 PM Navigating Digital Health: When Software Becomes a Medical Device – Critical Legal Considerations for Technology Suppliers in the Healthcare Sector By Henri Kaikkonen As digital health applications become increasingly sophisticated and telemedicine (the distribution of health-related information and...
3/31/2025 10:23:09 AM Health Data Holders’ obligations under the EHDS: What, When, and How Will We Know. By Benedicte Mourisse Marc Martens On 5 March 2025, the European Health Data Space (EHDS) Regulation was officially published in the Official Journal of the European Union....
2/19/2025 2:57:21 PM Increased risks for Australian life sciences businesses under the EU’s modernised product liability regime By Rebecca Currey Tom Johnston A recent EU directive will have significant consequences for Australian life sciences companies operating in Europe. Directive 2024/2853...
2/11/2025 3:50:42 PM Medical Devices in the UK: Changes to Post-Market Surveillance By Sophie Vo Quinn Liang On 11 December 2024, the MHRA published an updated roadmap for the future of the regulatory framework for medical devices in the UK,...
2/11/2025 8:39:19 AM Strengthening Pharma IP: China’s Boost to Data and Market Exclusivity By Alison Wong * This article was co-authored with Olivia Zhao from Bird & Bird Lawjay Shanghai association team. On 3 January 2025, the General Office...
1/22/2025 11:28:54 AM EMA’s finalised reflection paper on the use of AI By Hester Borgers Maud van Haaren On 9 September 2024 the European Medicines Agency (“EMA”) issued its final reflection paper on the use of AI in the medicinal product...
1/13/2025 11:15:48 AM EMA and HMA Update Guidance on Commercially Confidential Information in Marketing Authorisation Applications By Benedicte Mourisse Marc Martens The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have announced a significant update to their guidance on...
9/5/2024 1:59:03 PM What do the Political Guidelines for the Next European Commission bring to the life sciences & healthcare industry? By Hester Borgers Ana-Maria Barbu-Nyström On 18 July 2024 President Von der Leyen laid down the path for the next European Commission in her Political Guidelines for the next...
7/30/2024 11:47:36 AM New Draft Cybersecurity Act in the Netherlands: What you need to know By Wilfred Steenbruggen Puck van den Bosch In May 2024, the Dutch government published the draft bill for the new Cybersecurity Act (Cyberbeveiligingswet – “CSA”) for consultation...
6/18/2024 10:05:00 AM CJEU AG opinion: pharmaceutical company has EU VAT refund rights following ex lege payments to state health insurance body By Andy van Esdonk On June 6, 2024, the Advocate General (AG) at the Court of Justice of the European Union (CJEU) delivered an opinion in case C-248/23...
4/30/2024 10:30:00 AM Developments in the Netherlands on preventing unwanted influence of healthcare professionals by medical companies By Hester Borgers Jephta Zantinge On 8 April 2024, the Dutch Minister of Medical Care (the Minister) sent a letter to the Dutch House of Representatives (Kamerbrief)...
9/28/2023 9:59:00 AM Circular economy: what impact for healthcare players? By Alexandre Vuchot Johanna Harelimana Nour Saab Environmental awareness and the desire to limit or eliminate the impact of human activities on the environment have led to real political...